Shares of Enovix Co. (NASDAQ:ENVX - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eleven research firms that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $20.50.
ENVX has been the subject of several research analyst reports. Janney Montgomery Scott lowered shares of Enovix from a "buy" rating to a "neutral" rating and set a $10.00 target price for the company. in a research note on Thursday, October 31st. Cantor Fitzgerald reiterated an "overweight" rating and issued a $30.00 target price on shares of Enovix in a report on Wednesday, October 30th. Benchmark reissued a "buy" rating and issued a $25.00 target price on shares of Enovix in a research report on Wednesday, October 30th. Oppenheimer restated an "outperform" rating and set a $36.00 price target on shares of Enovix in a research report on Monday, August 26th. Finally, JPMorgan Chase & Co. cut their price objective on Enovix from $18.00 to $15.00 and set an "overweight" rating on the stock in a report on Tuesday, October 22nd.
View Our Latest Stock Report on Enovix
Insider Buying and Selling at Enovix
In related news, insider Arthi Chakravarthy sold 35,000 shares of the business's stock in a transaction dated Monday, October 14th. The stock was sold at an average price of $13.00, for a total value of $455,000.00. Following the transaction, the insider now owns 343,305 shares in the company, valued at $4,462,965. The trade was a 9.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. 15.70% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Enovix
Several hedge funds have recently modified their holdings of ENVX. Prospera Private Wealth LLC purchased a new stake in Enovix in the 3rd quarter valued at approximately $27,000. Blue Trust Inc. boosted its stake in shares of Enovix by 102.1% in the second quarter. Blue Trust Inc. now owns 1,894 shares of the company's stock valued at $29,000 after buying an additional 957 shares in the last quarter. GAMMA Investing LLC grew its holdings in Enovix by 11,176.2% during the second quarter. GAMMA Investing LLC now owns 2,368 shares of the company's stock worth $37,000 after acquiring an additional 2,347 shares during the period. Strategic Investment Solutions Inc. IL acquired a new position in Enovix during the second quarter worth $39,000. Finally, Voisard Asset Management Group Inc. raised its position in Enovix by 40.0% in the third quarter. Voisard Asset Management Group Inc. now owns 7,000 shares of the company's stock worth $65,000 after acquiring an additional 2,000 shares in the last quarter. 50.92% of the stock is owned by institutional investors and hedge funds.
Enovix Trading Up 10.4 %
Shares of ENVX stock traded up $0.96 during trading on Monday, hitting $10.21. 12,217,492 shares of the stock traded hands, compared to its average volume of 5,605,539. Enovix has a 52-week low of $5.70 and a 52-week high of $18.68. The firm has a market capitalization of $1.82 billion, a P/E ratio of -6.74 and a beta of 1.99. The firm's fifty day moving average price is $10.05 and its 200-day moving average price is $11.32. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61.
Enovix (NASDAQ:ENVX - Get Free Report) last posted its earnings results on Tuesday, October 29th. The company reported ($0.17) EPS for the quarter, beating analysts' consensus estimates of ($0.20) by $0.03. The company had revenue of $4.30 million for the quarter, compared to the consensus estimate of $4.11 million. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. During the same quarter in the previous year, the business earned ($0.27) earnings per share. As a group, research analysts forecast that Enovix will post -1.17 earnings per share for the current fiscal year.
Enovix Company Profile
(
Get Free ReportEnovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
See Also
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.